blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0324377

EP0324377 - Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.02.1998
Database last updated on 15.05.2024
Most recent event   Tooltip20.02.1998No opposition filed within time limitpublished on 08.04.1998 [1998/15]
Applicant(s)For all designated states
E. I. du Pont de Nemours and Company
1007 Market Street
Wilmington, DE 19898 / US
[N/P]
Former [1989/35]For all designated states
E.I. DU PONT DE NEMOURS AND COMPANY
1007 Market Street
Wilmington Delaware 19898 / US
Former [1989/29]For all designated states
E.I. DU PONT DE NEMOURS AND COMPANY
Barley Plaza, Building 17, P.O. Box 80017
Wilmington, DE 19880-0017 / US
Inventor(s)01 / Carini, David John
1921 Julian Road
Wilmington Delaware 19803 / US
02 / Wong, Pancras Chor Bun
3227 Whiteman Road
Wilmington Delaware 19808 / US
03 / Duncia, John Jonas Vytautas
35-B Martine Court
Newark Delaware 19711 / US
[1989/29]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [1989/29]von Kreisler, Alek, Dipl.-Chem., et al
Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41
D-50462 Köln / DE
Application number, filing date89100144.805.01.1989
[1989/29]
Priority number, dateUS1988014258007.01.1988         Original published format: US 142580
US1988027919406.12.1988         Original published format: US 279194
[1989/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0324377
Date:19.07.1989
Language:EN
[1989/29]
Type: A3 Search report 
No.:EP0324377
Date:06.02.1991
Language:EN
[1991/06]
Type: B1 Patent specification 
No.:EP0324377
Date:16.04.1997
Language:EN
[1997/16]
Search report(s)(Supplementary) European search report - dispatched on:EP19.12.1990
ClassificationIPC:C07D233/68, A61K31/415, C07D233/70, C07D233/84, C07D233/90, C07D233/94, C07D233/54, C07D233/64, C07D403/10, C07D405/10, C07D409/10
[1991/10]
CPC:
C07D233/64 (EP); A61P13/02 (EP); A61P15/00 (EP);
A61P9/12 (EP); C07D231/12 (EP); C07D233/56 (EP);
C07D233/68 (EP); C07D233/70 (EP); C07D233/84 (EP);
C07D233/90 (EP); C07D249/08 (EP); C07D401/06 (EP);
C07D403/04 (EP); C07D403/06 (EP); C07D403/10 (EP);
C07D403/14 (EP); C07D405/06 (EP); C07D405/10 (EP);
C07D409/10 (EP); C07F9/6506 (EP) (-)
Former IPC [1989/29]C07D233/64, C07D233/68, C07D403/10, A61K31/415
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/29]
TitleGerman:Angiotensin-II-Rezeptor blockende Imidazole und deren Kombinationen mit Diuretica und NSAids[1989/29]
English:Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids[1989/29]
French:Imidazoles à activité bloquante de récepteur de l'angiotensine II et leurs combinaisons avec des agents diurétiques et NSaids[1989/29]
MiscellaneousEPB 1997/16: (deleted)
EPB 1997/16: (deleted)
EPB 1997/16: (deleted)
EPB 1996/34: Teilanmeldung 96107930.8 eingereicht am 17/05/96
EPB 1996/34: Divisional application 96107930.8 filed on 17/05/96
EPB 1996/34: Demande divisionnaire 96107930.8 déposée le 17/05/96
Examination procedure06.12.1990Examination requested  [1991/05]
30.11.1993Despatch of a communication from the examining division (Time limit: M06)
27.05.1994Reply to a communication from the examining division
02.12.1994Despatch of a communication from the examining division (Time limit: M06)
30.05.1995Reply to a communication from the examining division
01.03.1996Despatch of communication of intention to grant (Approval: No)
24.06.1996Despatch of communication of intention to grant (Approval: later approval)
27.06.1996Communication of intention to grant the patent
13.08.1996Fee for grant paid
13.08.1996Fee for publishing/printing paid
Divisional application(s)EP96107930.8  / EP0733366
Opposition(s)17.01.1998No opposition filed within time limit [1998/15]
Fees paidRenewal fee
21.12.1990Renewal fee patent year 03
25.01.1992Renewal fee patent year 04
26.01.1993Renewal fee patent year 05
28.01.1994Renewal fee patent year 06
27.01.1995Renewal fee patent year 07
27.01.1996Renewal fee patent year 08
29.01.1997Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]GB2041363  (PFIZER LTD);
 [AD]US4226878  (IIZUKA KINJI, et al);
 [AD]US4340598  (FURUKAWA YOSHIYASU, et al);
 [AD]US4355040  (FURUKAWA YOSHIYASU, et al);
 [A]EP0103647  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [AP]EP0284375  (SMITHKLINE BECKMAN CORP [US]);
 [AP]EP0289919  (BASF AG [DE]);
 [AP]EP0291969  (DU PONT [US])
by applicantUS3772315
 US4207324
 US4226878
 US4340598
 US4355040
 US4379927
 EP0103647
 US4448781
 EP0125033
 EP0146228
 EP0235310
 EP0291969
    - B. TORII, TAKEDA KENKYUSHOHO, (1982), vol. 41, no. 3/4, pages 180 - 191
    - PALS ET AL., CIRCULATION RESEARCH, (1971), vol. 29, page 673
    - "Clinical Pharmacology of Antihypertensive Drugs", STREETEN; ANDERSON, Handbook of Hypertension, ELSEVIER SCIENCE PUBLISHERS B.V., (1984), vol. 5, page 246
    - KEETON, T. K.; CAMPBELL, W.B., PHARMACOL. REV., (1981), vol. 31, page 81
    - WEINBERGER, Y.H., MEDICAL CLINICS, (1987), vol. 71, page 979
    - DUNN, Y.J., HOSPITAL PRACTICE, (1984), vol. 19, page 99
    - SATOH ET AL., CIRC. RES., (1975), vol. 36/37, no. I, page I-89
    - BLASINGHAM ET AL., AM. J. PHYSIOL., (1980), vol. 239, page F360
    - WONG ET AL., J. PHARMACOL. EXP. THER., (1980), vol. 219, page 104
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.